Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for Differentiation-Reference-Cited by-同舟云学术

Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for Differentiation

Published:2015-04-22 Issue:4 Volume:10 Page:e0123181
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Brendel Cornelia,Teichler Sabine,Millahn Axel,Stiewe Thorsten,Krause Michael,Stabla Kathleen,Ross Petra,Huynh Minh,Illmer Thomas,Mernberger Marco,Barckhausen Christina,Neubauer Andreas

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. Network TCGAR Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia;N Engl J Med,2013

2. RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years;DT Bowen;Blood,2005

3. FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia;DL Stirewalt;Blood,2001

4. Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study;A Neubauer;J Clin Oncol,2008

5. Second hit mutations in the RTK/RAS signaling pathway in acute myeloid leukemia with inv(16);PJ Valk;Haematologica,2004

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disruption of dNTP homeostasis by ribonucleotide reductase hyperactivation overcomes AML differentiation blockade;Blood;2022-06-30

2. Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia;Leukemia;2021-02-12

3. Revealing the anticancer potential of candidate drugs in vivo using Caenorhabditis elegans mutant strains;Translational Oncology;2021-01

4. Advances in Diagnosis and Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes;Cancer Treatment and Research;2021

5. Grb2 inhibition: a new potential targeted therapy for myeloid malignancies?;The Lancet Haematology;2018-04